Indanylacetic acid derivatives carrying aryl-pyridyl and aryl-pyrimidinyl tail groups—new classes of PPAR γ/δ and PPAR α/γ/δ agonists-Reference-Cited by-同舟云学术

Indanylacetic acid derivatives carrying aryl-pyridyl and aryl-pyrimidinyl tail groups—new classes of PPAR γ/δ and PPAR α/γ/δ agonists

Published:2007-02 Issue:4 Volume:17 Page:1056-1061
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Cantin Louis-David,Liang Sidney,Ogutu Herbert,Iwuagwu Christiana I.,Boakye Ken,Bullock William H.,Burns Michael,Clark Roger,Claus Thomas,delaCruz Fernando E.,Daly Michelle,Ehrgott Frederick J.,Johnson Jeffrey S.,Keiper Christine,Livingston James N.,Schoenleber Robert W.,Shapiro Jeffrey,Town Christopher,Yang Ling,Tsutsumi Manami,Ma Xin

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference12 articles.

1. Type 2 diabetes: principles of pathogenesis and therapy

2. Global and societal implications of the diabetes epidemic

3. Oral Antidiabetic Agents

4. The Clinical Significance of PPAR Gamma Agonism

5. Therapeutic Roles of Peroxisome Proliferator–Activated Receptor Agonists

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modeling habitat connectivity in support of multiobjective species movement: An application to amphibian habitat systems;PLOS Computational Biology;2020-12-28

2. Advances and Challenges in Drug Design of PPARδ Ligands;Current Drug Targets;2018-01-18

3. Multitargeted bioactive ligands for PPARs discovered in the last decade;Chemical Biology & Drug Design;2016-07-21

4. Nanocrystalline Titania-Supported Palladium(0) Nanoparticles for Suzuki-Miyaura Cross-Coupling of Aryl and Heteroaryl Halides;Advanced Synthesis & Catalysis;2011-10

5. Docking and Molecular Dynamics Simulations of Peroxisome Proliferator Activated Receptors Interacting with Pan Agonist Sodelglitazar;Protein & Peptide Letters;2011-10-01